Why the study?
Does overexpression of IGF-1 prevent myocyte death and attenuate ventricular remodeling after myocardial infarction in mice?
Does overexpression of IGF-1 prevent myocyte death and attenuate ventricular remodeling after myocardial infarction in mice?
Constitutive overexpression of IGF-1 in mice protects against myocyte apoptosis and necrosis after myocardial infarction, thereby limiting ventricular dilation and hypertrophy.
Answers are grounded in this paper and cite their sources.
Reduces post-MI remodeling in mice; leaves open whether IGF-1 modulation affects human ventricular dilation.
To determine whether IGF-1 opposes the stimulation of myocyte death in the surviving myocardium after infarction, transgenic mice overexpressing human IGF-1B in myocytes (FVB.Igf+/-) and wild-type littermates at 1.5 and 2.5 mo of age were subjected to coronary ligation and killed 7 d later. Myocardial infarction involved an average 50% of the left ventricle, and produced cardiac failure. In the region proximate to infarction, myocyte apoptosis increased 4. 2-fold and 2.1-fold in nontransgenics at 1.5 and 2.5 mo, respectively. Corresponding increases in myocyte necrosis were 1. 8-fold and 1.6-fold. In contrast, apoptotic and necrotic myocyte death did not increase in FVB.Igf+/- mice at either age after infarction. In 2.5-mo-old infarcted nontransgenics, functional impairment was associated with a 29% decrease in wall thickness, 43% increase in chamber diameter, and a 131% expansion in chamber volume. Conversely, the changes in wall thickness, chamber diameter, and cavitary volume were 41, 58, and 48% smaller in infarcted FVB.Igf+/- than in nontransgenics. The differential response to infarction of FVB.Igf+/- mice resulted in an attenuated increase in diastolic wall stress, cardiac weight, and left and right ventricular weight-to-body wt ratios. In conclusion, constitutive overexpression of IGF-1 prevented activation of cell death in the viable myocardium after infarction, limiting ventricular dilation, myocardial loading, and cardiac hypertrophy.
No takes yet. Share an insight, caveat, or question.
Li et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: